Use access key #2 to skip to page content.
$45.15 1.00 (2.27%)
7/18/2008 4:00 PM

ImClone Systems, Inc. (IMCL)

CAPS Rating:
***

A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.

View Ticker Page (IMCL)

Results 0 - 0 of 0 :

For some bizarre technical reason, the CAPS system was unable to retrieve pitches for the ticker symbol IMCL. Please try again later.

Featured Broker Partners